R&D Systems™ Recombinant Human ELFN2 Fc Chimera Protein

Catalog No.	Quantity
10643EF050	50 μg

Catalog No. 10643EF050 Supplier R&D Systems™ Supplier No. 10643EF050

Description

Measured by its binding ability in a functional ELISA. When Recombinant Human mGluR7 Protein (Catalog # 9530-UR ) is coated at 1 μg/mL, 100 μL/well, Recombinant Human ELFN2 Fc Chimera binds with an ED50 of 0.15-0.75 μg/mL.

Specifications

• Accession Number: Q5R3F8.1
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Gene ID (Entrez): 114794
• Molecular Weight (g/mol): M.W.-observed: 97-112 kDa, under reducing conditions, M.W.-theroretical: 69 kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell, HEK293-derived human ELFN2 protein Human ELFN2 (Asp23-Tyr397) (N-terminus) Accession # Q5R3F8.1 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <1.0 EU / 1 μg of the protein by the LAL method.
• Gene Alias: dJ63G5.3, dJ63G5.3 (putative Leucine rich protein), ELFN2, extracellular leucine-rich repeat and fibronectin type III containing 2, extracellular leucine-rich repeat and fibronectin type III domain containing 2, extracellular leucine-rich repeat and fibronectin type III domain-containing protein 2, KIAA1904, leucine rich repeat containing 62, leucine-rich repeat and fibronectin type-III domain-containing protein 6, leucine-rich repeat-containing protein 62, LRRC62, PPP1R29, protein phosphatase 1, regulatory subunit 29
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: ELFN2